[go: up one dir, main page]

PL1971332T3 - Zastosowanie soli tiotropium w leczeniu umiarkowanej uporczywej astmy - Google Patents

Zastosowanie soli tiotropium w leczeniu umiarkowanej uporczywej astmy

Info

Publication number
PL1971332T3
PL1971332T3 PL06830792T PL06830792T PL1971332T3 PL 1971332 T3 PL1971332 T3 PL 1971332T3 PL 06830792 T PL06830792 T PL 06830792T PL 06830792 T PL06830792 T PL 06830792T PL 1971332 T3 PL1971332 T3 PL 1971332T3
Authority
PL
Poland
Prior art keywords
treatment
tiotropium salts
persistent asthma
moderate persistent
moderate
Prior art date
Application number
PL06830792T
Other languages
English (en)
Inventor
Michael Engel
Stefan Heinrichs
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35695896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1971332(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PL1971332T3 publication Critical patent/PL1971332T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL06830792T 2006-01-04 2006-12-22 Zastosowanie soli tiotropium w leczeniu umiarkowanej uporczywej astmy PL1971332T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06100055 2006-01-04
PCT/EP2006/070135 WO2007077162A1 (en) 2006-01-04 2006-12-22 Use of tiotropium salts in the treatment of moderate persistent asthma
EP06830792A EP1971332B1 (en) 2006-01-04 2006-12-22 Use of tiotropium salts in the treatment of moderate persistent asthma

Publications (1)

Publication Number Publication Date
PL1971332T3 true PL1971332T3 (pl) 2011-08-31

Family

ID=35695896

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06830792T PL1971332T3 (pl) 2006-01-04 2006-12-22 Zastosowanie soli tiotropium w leczeniu umiarkowanej uporczywej astmy

Country Status (30)

Country Link
US (2) US20070155773A1 (pl)
EP (1) EP1971332B1 (pl)
JP (1) JP2009525950A (pl)
KR (1) KR20080083060A (pl)
CN (1) CN101355937A (pl)
AR (1) AR059126A1 (pl)
AT (1) ATE500825T1 (pl)
AU (1) AU2006334367B2 (pl)
BR (1) BRPI0620886A2 (pl)
CA (1) CA2634984C (pl)
CY (1) CY1111534T1 (pl)
DE (1) DE602006020620D1 (pl)
DK (1) DK1971332T3 (pl)
EA (1) EA015353B1 (pl)
EC (1) ECSP088588A (pl)
ES (1) ES2362306T3 (pl)
HR (1) HRP20110200T1 (pl)
IL (1) IL192602A (pl)
ME (1) ME01205B (pl)
MY (1) MY146362A (pl)
NO (1) NO20082439L (pl)
NZ (1) NZ570162A (pl)
PL (1) PL1971332T3 (pl)
PT (1) PT1971332E (pl)
RS (1) RS51703B (pl)
SI (1) SI1971332T1 (pl)
TW (1) TW200731976A (pl)
UA (1) UA95271C2 (pl)
WO (1) WO2007077162A1 (pl)
ZA (1) ZA200804436B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009504604A (ja) 2005-08-06 2009-02-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 重症持続型喘息の治療におけるチオトロピウム塩の使用
WO2015065222A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащий в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
GB201321717D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
CN110876721A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 一种含有表面活性剂的噻托溴铵喷雾剂
CN110876720A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 依地酸盐恰当改变噻托溴铵喷雾剂表面张力的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2425539A (en) * 1942-10-31 1947-08-12 Aro Equipment Corp Coupling
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
US6156503A (en) * 1997-03-03 2000-12-05 The Regents Of The University Of California Diagnosing asthma patients predisposed to adverse β-agonist reactions
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
EP1326862B1 (de) * 2000-10-12 2004-09-15 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Kristallines monohydrat von tiotropiumbromid, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
US6608055B2 (en) * 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
US7951557B2 (en) * 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
ES2338563T3 (es) * 2003-11-03 2010-05-10 Boehringer Ingelheim International Gmbh Nuevo anhidrato cristalino con efecto anticolinergico.
PL2067779T3 (pl) * 2003-11-03 2013-09-30 Boehringer Ingelheim Int Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne
US7968717B2 (en) * 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
KR20080011289A (ko) * 2005-05-10 2008-02-01 시너젠즈 바이오사이언스 리미티드 폐기능 및 폐질환을 평가하기 위한 성분 및 평가 방법
EP1888779A4 (en) * 2005-05-20 2009-06-10 Synergenz Bioscience Ltd METHOD FOR THE ANALYSIS OF POLYMORPHISMS AND USES THEREOF
JP2009504604A (ja) * 2005-08-06 2009-02-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 重症持続型喘息の治療におけるチオトロピウム塩の使用
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide

Also Published As

Publication number Publication date
DE602006020620D1 (de) 2011-04-21
EA015353B1 (ru) 2011-06-30
CY1111534T1 (el) 2015-08-05
EP1971332A1 (en) 2008-09-24
EA200801629A1 (ru) 2008-12-30
SI1971332T1 (sl) 2011-05-31
ECSP088588A (es) 2008-07-30
BRPI0620886A2 (pt) 2011-11-29
TW200731976A (en) 2007-09-01
JP2009525950A (ja) 2009-07-16
IL192602A0 (en) 2009-09-22
UA95271C2 (ru) 2011-07-25
AU2006334367A1 (en) 2007-07-12
DK1971332T3 (da) 2011-04-18
AR059126A1 (es) 2008-03-12
ZA200804436B (en) 2008-12-31
NZ570162A (en) 2011-09-30
NO20082439L (no) 2008-08-04
ATE500825T1 (de) 2011-03-15
EP1971332B1 (en) 2011-03-09
CA2634984A1 (en) 2007-07-12
CA2634984C (en) 2014-05-06
AU2006334367B2 (en) 2012-11-08
ME01205B (me) 2013-03-20
CN101355937A (zh) 2009-01-28
HRP20110200T1 (hr) 2011-04-30
IL192602A (en) 2013-06-27
ES2362306T3 (es) 2011-07-01
MY146362A (en) 2012-08-15
US20150224090A1 (en) 2015-08-13
PT1971332E (pt) 2011-03-18
WO2007077162A1 (en) 2007-07-12
RS51703B (en) 2011-10-31
US20070155773A1 (en) 2007-07-05
KR20080083060A (ko) 2008-09-12

Similar Documents

Publication Publication Date Title
IL262838A (en) Guanylate cyclase agonists for use in the treatment of hypercholesterolemia
IL195400A0 (en) Aldh-2 inhibitors in the treatment of addiction
ZA201000075B (en) Purin derivatives for use in the treatment of fab-related diseases
HK1146596A1 (en) Use of lingo-4 antagonists in the treatment of conditions involving demyelination lingo-4
GB0625659D0 (en) Therapeutic compounds and their use
HK1148284A1 (en) Isoxazolopyridine derivatives for use in the treatment of hif-mediated conditions hif
SI1978947T1 (sl) Nitrooksiderivati za uporabo pri zdravljenju mišičnih distrofij
PL2101731T3 (pl) Endoksyfen do zastosowania w leczeniu nowotworu
IL195152A (en) Compounds for use in treating diseases of cell culture
HK1129426A1 (zh) 用於治療肺部病症的酶的合成物
IL205939A (en) Compounds for use in the treatment of lysosomal disorders
AU2008303948A8 (en) Use of the peptide Asn-Asp-Asp-Cys-Glu- Leu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu alone or in combination with the peptide Thr-Thr-Ser-Gln-Val- Arg-Pro-Arg as a therapeutic agent
HK1129585A1 (en) Compound for use in the treatment of valvular stenosis
HK1209053A1 (zh) 地來西坦在慢性疼痛的治療中的用途
IL182407A0 (en) Use of agomelating in obtaining medicaments intended for the treatment of generalized anxiety disorder
IL212672A (en) Cycloandesdepsipeptide compounds and their use in drug production
GB0714447D0 (en) Cannabidiol for use in the treatment of neurodegenerative conditions
IL192602A0 (en) Use of tiotropium salts in the treatment of moderate persistent asthma
HK1134032A1 (en) New combination for use in the treatment of inflammatory disorders
ZA201108106B (en) Use of phthalimide derivatives in the treatment of diseases
IL189248A0 (en) Use of tiotropium salts in the treatment of severe persistant asthma
GB0622479D0 (en) Novel salts and their therapeutic use
EP2421552B8 (en) Collagen v for use in the treatment of asthma
EP2363132A4 (en) USE OF SOPHORICOSIDE IN DRUG MANUFACTURE
SI2182954T1 (sl) Uporaba nor-žolčnih kislin pri zdravljenju arterioskleroze